Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00469859 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia

Interventions

DRUG: cytarabine
DRUG: idarubicin
DRUG: lestaurtinib

Sponsor

Children's Oncology Group

Collaborators

[object Object]